Join Matindale-Hubbell Connected



Search Results (2672)

  
Documents on biotech life sciences
 

View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLU.S. Government and USPTO Urges Federal Circuit to Dismiss Stem Cell Appeal
Antoinette F. Konski; Foley & Lardner LLP;
Legal Alert/Article
February 5, 2014, previously published on February 3, 2014
On January 17, 2014, the United States government and the United States Patent and Trademark Office (collectively “the government”) responded to the Federal Circuit’s December 4, 2013 order inviting them to address whether Consumer Watchdog (“CW”) has Article III...

 

HTMLUSPTO Proposes Real Party in Interest Patent Rules
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
February 3, 2014, previously published on January 27, 2014
A year after its “Roundtable on Proposed Requirements for Recordation of Real Party-in-Interest Information Throughout Application Pendency and Patent Term,” and six months after the White House Task Force on High-Tech Patent Issues made requiring patent applicants and owners to...

 

HTMLFDA Issues New Draft Guidance for Custom Devices; Some Points Worth Highlighting
Jeffrey K. Shapiro; Hyman, Phelps & McNamara, P.C.;
Legal Alert/Article
January 31, 2014, previously published on January 27, 2014
FDA has issued a new draft guidance on the custom device exemption. Comments are due by March 17, 2014. This schedule puts FDA on track to finalize the guidance by July 9, 2014, as required under section 617 of the Food and Drug Administration Safety and Innovation Act (“FDASIA”) (Pub....

 

HTMLSupreme Court Lays Burden of Proof on Patentee, Even in Declaratory Judgment Action
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
January 29, 2014, previously published on January 22, 2014
In Medtronic, Inc. v. Mirowski Family Ventures, LLC, a unanimous Supreme Court held that the patent holder bears the burden of proving infringement, even in a declaratory judgment action brought by a licensee. In reaching its decision, the Court dismissed concerns that it would skew the balance of...

 

HTMLPatent Owners’ Heavy Burdens: Proof of Infringement
Elizabeth Ann Lester, William L. Warren; Sutherland Asbill & Brennan LLP;
Legal Alert/Article
January 29, 2014, previously published on January 24, 2014
The U.S. Supreme Court reversed the U.S. Court of Appeals for the Federal Circuit in a unanimous opinion in Medtronic, Inc. v. Mirowski Family Ventures, LLC, No. 12-1128, on January 22, 2014, holding that patent owners bear the burden of proving infringement when a licensee seeks a declaratory...

 

HTMLSupreme Court Grants Certiorari in Nautilus v. Biosig Instruments
Michael G. Raucci; Sughrue Mion, PLLC;
Legal Alert/Article
January 23, 2014, previously published on January 15, 2014
On January 10, 2014, the Supreme Court granted certiorari in Nautilus v. Biosig Instruments (13-369) to decide the proper standard for finding patented claims indefinite under 35 U.S.C. § 112. At issue is whether the Federal Circuit’s construction of § 112, ¶ 2 conflicts with...

 

HTMLGodot Finally Arrives: At Long Last, FDA Issues Draft Guidance On Submissions For Interactive Social Media
Delia A. Deschaine, Jeffrey N. Wasserstein; Hyman, Phelps & McNamara, P.C.;
Legal Alert/Article
January 21, 2014, previously published on January 16, 2014
For years, those of us who followed FDA’s attempt to provide guidance related to social media felt like Vladimir and Estragon from Samuel Beckett’s Waiting for Godot. FDA initially promised guidance by the end of 2010. But, like Godot, the guidance never came. On January 13, after...

 

HTMLSupreme Court to Consider Legal Standard for Patent Indefiniteness
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
January 14, 2014, previously published on January 13, 2014
On January 10, 2014, the U.S. Supreme Court granted certiorari in Nautilus Inc. v. Biosig Instruments, Inc., to review the legal standard for holding a patent claim invalid as indefinite, under 35 USC § 112, second paragraph.

 

HTMLMedtronic Orders Recall of Dangerous Defective Medical Devices
James P. Nevin; Brayton Purcell, LLP;
Legal Alert/Article
January 10, 2014, previously published on January 9, 2014
The Food and Drug Administration has classified the recall of "some Medtronic devices used during heart procedures" as Class I, a category reserved for products with reasonable potential to cause serious injury or death. An estimated 15,000 devices made since April 2013 are affected by...

 

HTMLInstitut Pasteur Obtains Reversal of USPTO Board Decision of Obviousness of Eukaryotic Site-Directed Mutagenesis Methods
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
January 9, 2014, previously published on January 7, 2014
In Institut Pasteur v. Focarino, the Federal Circuit found that the obviousness determination by the USPTO Board of Patent Appeals and Interferences was not supported by substantial evidence, and rested on an “erroneous obviousness analysis.” It dismissed the appeal as to one patent,...

 


View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>